Ainos, Inc. (AIMD)
NASDAQ: AIMD · Real-Time Price · USD
0.620
-0.010 (-1.56%)
Feb 21, 2025, 4:00 PM EST - Market closed
Ainos Revenue
Ainos had revenue of $40.63K in the twelve months ending September 30, 2024, down -96.44% year-over-year. In the year 2023, Ainos had annual revenue of $122.11K, down -96.53%.
Revenue (ttm)
$40.63K
Revenue Growth
-96.44%
P/S Ratio
106.55
Revenue / Employee
$883
Employees
46
Market Cap
8.74M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 122.11K | -3.40M | -96.53% |
| Dec 31, 2022 | 3.52M | 2.93M | 491.97% |
| Dec 31, 2021 | 594.56K | 578.00K | 3,489.71% |
| Dec 31, 2020 | 16.56K | 4.83K | 41.19% |
| Dec 31, 2019 | 11.73K | -65.99K | -84.91% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 400.28B |
| Johnson & Johnson | 88.82B |
| Merck & Co. | 64.17B |
| AbbVie | 56.33B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.88B |
AIMD News
- 26 days ago - Ainos Achieves Major Breakthrough: Japan Patent Approval for VELDONA Redefines Antiviral Innovation - Accesswire
- 4 weeks ago - Water Tower Research Spotlights Ainos' AI Nose Programs and Strategic Milestones for 2025 - Accesswire
- 5 weeks ago - Ainos Granted 180-Day Extension by Nasdaq to Regain Compliance With Minimum Bid Price Rule - Accesswire
- 5 weeks ago - Ainos Unveils AI Nose for Robotics: Invites Global Robotics Companies to Join Forces in Shaping the Future of Smell-Enabled Robots - Accesswire
- 2 months ago - CORRECTION BY SOURCE: Smell the Future: Ainos Elevates Health and Technology With AI Nose and VELDONA - Accesswire
- 2 months ago - Smell the Future: Ainos Elevates Health and Technology With AI Nose and VELDONA - Accesswire
- 2 months ago - Ainos Joins Webull Corporate Connect Service Platform to Enhance Investor Engagement - Accesswire
- 2 months ago - Water Tower Research Underscores Ainos' Partnership With Taiwan Tanabe Seiyaku for VELDONA Manufacturing and Marketing - Accesswire